A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer

Abstract De-escalating adjuvant therapy following pathologic complete response (pCR) to an abbreviated neoadjuvant regimen in human epidermal growth factor receptor 2-positive (HER2+) breast cancer is the focus of international research efforts. However, the feasibility of this approach and its appe...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Adrienne G. Waks, Neelam V. Desai, Tianyu Li, Philip D. Poorvu, Ann H. Partridge, Natalie Sinclair, Laura M. Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jillian Alberti, Julia Deane, Shoshana M. Rosenberg, Elizabeth Frank, Sara M. Tolaney, Ian E. Krop, Nadine M. Tung, Nabihah Tayob, Tari A. King, Elizabeth A. Mittendorf, Eric P. Winer
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Portfolio 2022-05-01
Serie:npj Breast Cancer
Länkar:https://doi.org/10.1038/s41523-022-00429-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk